Taina Sipponen

3.8k total citations
66 papers, 2.8k citations indexed

About

Taina Sipponen is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Taina Sipponen has authored 66 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Genetics, 38 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Taina Sipponen's work include Inflammatory Bowel Disease (51 papers), Microscopic Colitis (33 papers) and Eosinophilic Esophagitis (10 papers). Taina Sipponen is often cited by papers focused on Inflammatory Bowel Disease (51 papers), Microscopic Colitis (33 papers) and Eosinophilic Esophagitis (10 papers). Taina Sipponen collaborates with scholars based in Finland, United Kingdom and Sweden. Taina Sipponen's co-authors include Kaija‐Leena Kolho, Martti Färkkilâ, Ulla Turunen, Hannu Nuutinen, Erkki Savilahti, Clas-Göran af Björkesten, Päivi Kärkkäinen, Perttu Arkkila, Urpo Nieminen and Pauliina Molander and has published in prestigious journals such as Gastroenterology, PLoS ONE and Frontiers in Microbiology.

In The Last Decade

Taina Sipponen

64 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taina Sipponen Finland 28 2.2k 1.7k 1.1k 662 295 66 2.8k
Ulla Turunen Finland 23 1.7k 0.8× 1.3k 0.8× 829 0.7× 477 0.7× 235 0.8× 44 2.3k
John Fell United Kingdom 18 1.5k 0.7× 1.1k 0.6× 818 0.7× 374 0.6× 185 0.6× 29 2.0k
Paul F. Pollack United States 21 3.7k 1.7× 3.2k 1.8× 1.2k 1.1× 956 1.4× 253 0.9× 49 4.5k
Henit Yanai Israel 28 1.8k 0.8× 1.3k 0.7× 923 0.8× 600 0.9× 436 1.5× 125 2.6k
J F Colombel United States 29 2.2k 1.0× 1.7k 1.0× 1.4k 1.2× 797 1.2× 294 1.0× 148 3.6k
Joaquín Hinojosa Spain 27 1.3k 0.6× 1.0k 0.6× 664 0.6× 446 0.7× 133 0.5× 90 2.2k
Ida Vind Denmark 24 1.7k 0.8× 1.4k 0.8× 804 0.7× 335 0.5× 172 0.6× 46 2.3k
Mathurin Fuméry France 29 2.2k 1.0× 1.7k 1.0× 1.0k 0.9× 788 1.2× 195 0.7× 198 3.3k
Guillaume Bouguen France 30 1.8k 0.8× 1.3k 0.7× 1.3k 1.2× 288 0.4× 250 0.8× 144 2.8k
Jean-Paul Achkar United States 24 2.0k 0.9× 1.4k 0.8× 1.2k 1.1× 351 0.5× 495 1.7× 31 2.9k

Countries citing papers authored by Taina Sipponen

Since Specialization
Citations

This map shows the geographic impact of Taina Sipponen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taina Sipponen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taina Sipponen more than expected).

Fields of papers citing papers by Taina Sipponen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taina Sipponen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taina Sipponen. The network helps show where Taina Sipponen may publish in the future.

Co-authorship network of co-authors of Taina Sipponen

This figure shows the co-authorship network connecting the top 25 collaborators of Taina Sipponen. A scholar is included among the top collaborators of Taina Sipponen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taina Sipponen. Taina Sipponen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Löyttyniemi, Eliisa, et al.. (2025). Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 70(4). 1457–1466.
2.
Björkesten, Clas-Göran af, Ritva Koskela, Aki Juhani Käräjämäki, et al.. (2025). Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study. European Journal of Gastroenterology & Hepatology. 37(4). 446–453. 1 indexed citations
3.
Ylisaukko‐oja, Tero, Clas-Göran af Björkesten, Airi Jussila, et al.. (2024). Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment. Heliyon. 10(12). e32432–e32432. 1 indexed citations
4.
Koffert, Jukka, Pia Oksanen, Airi Jussila, et al.. (2022). Combining biological therapies in patients with inflammatory bowel disease: a Finnish multi-centre study. Scandinavian Journal of Gastroenterology. 57(8). 936–941. 14 indexed citations
5.
Xu, Man, Katarzyna Leskinen, Tommaso Gritti, et al.. (2022). Prevalence, Cell Tropism, and Clinical Impact of Human Parvovirus Persistence in Adenomatous, Cancerous, Inflamed, and Healthy Intestinal Mucosa. Frontiers in Microbiology. 13. 914181–914181. 13 indexed citations
7.
Koulaouzidis, Anastasios, Taina Sipponen, Artúr Németh, et al.. (2016). Association Between Fecal Calprotectin Levels and Small-bowel Inflammation Score in Capsule Endoscopy: A Multicenter Retrospective Study. Digestive Diseases and Sciences. 61(7). 2033–2040. 27 indexed citations
8.
Molander, Pauliina, Martti Färkkilâ, Ari Ristimäki, et al.. (2014). Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?. Journal of Crohn s and Colitis. 9(1). 33–40. 83 indexed citations
9.
Mälkönen, Tarja, Anne Puustinen, Kaarina Heiskanen, et al.. (2014). Skin Reactions During Anti-TNFα Therapy for Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 20(8). 1309–1315. 44 indexed citations
10.
Nieminen, Janne, Taina Sipponen, Harri M. Salo, et al.. (2013). Dendritic Cells from Crohn’s Disease Patients Show Aberrant STAT1 and STAT3 Signaling. PLoS ONE. 8(8). e70738–e70738. 19 indexed citations
11.
Sipponen, Taina. (2013). Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin. Digestive Diseases. 31(3-4). 336–344. 49 indexed citations
12.
Molander, Pauliina, Taina Sipponen, Helena Kemppainen, et al.. (2012). Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD. Journal of Crohn s and Colitis. 7(9). 730–735. 88 indexed citations
13.
Lehtonen, Heli, Taina Sipponen, Sari Tojkander, et al.. (2012). Segregation of a Missense Variant in Enteric Smooth Muscle Actin γ-2 With Autosomal Dominant Familial Visceral Myopathy. Gastroenterology. 143(6). 1482–1491.e3. 65 indexed citations
14.
Sipponen, Taina, Ulla Turunen, Irmeli Lautenschlager, et al.. (2011). Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 46(11). 1324–1333. 25 indexed citations
15.
Sipponen, Taina & Kaija‐Leena Kolho. (2010). Faecal calprotectin in children with clinically quiescent inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 45(7-8). 872–877. 73 indexed citations
16.
Sipponen, Taina, Hannu Nuutinen, Ulla Turunen, & Martti Färkkilâ. (2010). Endoscopic evaluation of Crohnʼs disease activity. Inflammatory Bowel Diseases. 16(12). 2131–2136. 128 indexed citations
17.
Koivusalo, Antti, Mikko P. Pakarinen, Merja Ashorn, et al.. (2009). Sexual functions in adulthood after restorative proctocolectomy for paediatric onset ulcerative colitis. Pediatric Surgery International. 25(10). 881–884. 19 indexed citations
18.
Sipponen, Taina, Päivi Kärkkäinen, Erkki Savilahti, et al.. (2008). Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings. Alimentary Pharmacology & Therapeutics. 28(10). 1221–1229. 260 indexed citations
19.
Klemetti, Paula, Taina Sipponen, Mia Westerholm‐Ormio, et al.. (2008). IL-23/IL-17 immunity as a hallmark of Crohnʼs disease. Inflammatory Bowel Diseases. 14(9). 1175–1184. 167 indexed citations
20.
Sipponen, Taina, Erkki Savilahti, Kaija‐Leena Kolho, et al.. (2007). Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings. Inflammatory Bowel Diseases. 14(1). 40–46. 381 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026